Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Telepathology Market : By Services, By Application, By End-User and Region Forecast 2020-2031
Telepathology Market : By Services, By Application, By End-User and Region Forecast 2020-2031
Telepathology Market size was valued at US$ 852.1 million in 2024 and is expected to reach US$ 1,629.2 million by 2031, growing at a significant CAGR of 9.7% from 2025-2031. Telepathology referred as practising pathology from a distance and telecommunication technology is used for facilitating the transmission of pathology image rich data between two distant locations for diagnosis, research and education. Pathology plays a very important role in identifying the characteristics and causes of the diseases in medical field. Electronic medical records also increase the administrative efficiency and reduces the medical cost. There are three modes of telepathology are static (or store-and-forward), dynamic (or real-time) and hybrid (or virtual. Static telepathology refers to the process of pre-selection and digitalisation of representative image by sender pathologist and sending it to the remote pathologist via e-mail or internet. Dynamic telepathology is most appropriate system for frozen-selection telepathology and for understaffed area. This involves transmission of microscopic slide images to recipient in real time via live communication. Whereas, hybrid pathology is combining both static and dynamic telepathology modes, a series of images that automatically stitched together in a software, compressed to a single file form and transmitted on the dynamic telepathology session start. Telepathology Market is technology-driven segment of medical field. It is an innovative digital imaging and telecommunication technology that is changing the healthcare delivery systems globally. The regional players are involving in acquisition of the pathology providers that present locally and strengthening their position in market.
Study Period
2025-2031Base Year
2024CAGR
9.7%Largest Market
North-AmericaFastest Growing Market
Europe
The market is driven by the technological advancements, digitalization of pathology. In addition, extended reach, cost-effectiveness of the services and quick diagnosis are expected to bolster the market over the forecast period. Furthermore, ease of operation, increase in government funding for hospitals and growing demand for telemedicine are also expected to further boost the market growth during the forecast period. However, factors such as the high cost of devices, lack of skilled professionals, and lack of infrastructure in underdeveloped and developing countries expected to hamper the market growth over the forecast period. Moreover, monitoring of telepathology requires high amount of investment and errors in interpreting the digital data may act as restraints for the market growth.
Geographically, the market has been segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America market expected to grow at significant rates owing to the favourable healthcare policies that use digital pathology systems, well-established healthcare infrastructure and growing ageing population who are more susceptible to the physical problems that require imaging technologies for diagnosis. Europe market is expected to grow at notable rates owing to prevalence of the diseases such as cancer that require the pathological diagnosis, growing awareness and well-developed healthcare infrastructure. Asia Pacific region is expected to be a fastest growing market for telepathology owing to the developing healthcare infrastructure and digitalization of the medical services in order to deliver the cost-effective services. However, in developing countries such as India and China lack of skilled professionals and training for optimum utilisation of telepathology may hinder the market growth.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 852.1 million |
|
Market Size in 2031 |
US$ 1,629.2 million |
|
Market CAGR |
9.7% |
|
By Services |
|
|
By Application |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
Telepathology market size was valued at US$ 852.1 million in 2024 and is expected to reach US$ 1,629.2 million by 2031, growing at a significant CAGR of 9.7%.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
| 1.Executive Summary |
| 2.Global Telepathology Market Introduction |
| 2.1.Global Telepathology Market - Taxonomy |
| 2.2.Global Telepathology Market - Definitions |
| 2.2.1.Services |
| 2.2.2.Application |
| 2.2.3. End-user |
| 2.2.4.Region |
| 3.Global Telepathology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Telepathology Market Analysis, 2020-2024 and Forecast 2025-2031 |
| 4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Telepathology Market By Services , 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 5.1. Static Telepathology |
| 5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Dynamic Telepathology |
| 5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Hybrid Telepathology |
| 5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Telepathology Market By Application, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 6.1. Diagnosis |
| 6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Education |
| 6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Teleconsultation |
| 6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Research |
| 6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Telepathology Market By End-user, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 7.1. Pharmaceutical & Biotechnology Firms |
| 7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Hospitals, |
| 7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Academic Institutions |
| 7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Telepathology Market By Region, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Telepathology Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 9.1. Services Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Static Telepathology |
| 9.1.2.Dynamic Telepathology |
| 9.1.3.Hybrid Telepathology |
| 9.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Diagnosis |
| 9.2.2.Education |
| 9.2.3.Teleconsultation |
| 9.2.4.Research |
| 9.3. End-user Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Pharmaceutical & Biotechnology Firms |
| 9.3.2.Hospitals, |
| 9.3.3.Academic Institutions |
| 9.3.4.Others |
| 9.4. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Telepathology Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 10.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Static Telepathology |
| 10.1.2.Dynamic Telepathology |
| 10.1.3.Hybrid Telepathology |
| 10.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Diagnosis |
| 10.2.2.Education |
| 10.2.3.Teleconsultation |
| 10.2.4.Research |
| 10.3. End-user Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Pharmaceutical & Biotechnology Firms |
| 10.3.2.Hospitals, |
| 10.3.3.Academic Institutions |
| 10.3.4.Others |
| 10.4. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 10.4.7. |
| 11.Asia Pacific (APAC) Telepathology Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 11.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Static Telepathology |
| 11.1.2.Dynamic Telepathology |
| 11.1.3.Hybrid Telepathology |
| 11.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Diagnosis |
| 11.2.2.Education |
| 11.2.3.Teleconsultation |
| 11.2.4.Research |
| 11.3. End-user Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Pharmaceutical & Biotechnology Firms |
| 11.3.2.Hospitals, |
| 11.3.3.Academic Institutions |
| 11.3.4.Others |
| 11.4. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Telepathology Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 12.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Static Telepathology |
| 12.1.2.Dynamic Telepathology |
| 12.1.3.Hybrid Telepathology |
| 12.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Diagnosis |
| 12.2.2.Education |
| 12.2.3.Teleconsultation |
| 12.2.4.Research |
| 12.3. End-user Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Pharmaceutical & Biotechnology Firms |
| 12.3.2.Hospitals, |
| 12.3.3.Academic Institutions |
| 12.3.4.Others |
| 12.4. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Telepathology Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 13.1. Services Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Static Telepathology |
| 13.1.2.Dynamic Telepathology |
| 13.1.3.Hybrid Telepathology |
| 13.2. Application Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Diagnosis |
| 13.2.2.Education |
| 13.2.3.Teleconsultation |
| 13.2.4.Research |
| 13.3. End-user Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Pharmaceutical & Biotechnology Firms |
| 13.3.2.Hospitals, |
| 13.3.3.Academic Institutions |
| 13.3.4.Others |
| 13.4. Country Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Southeastern Pathology Associates (U.S.) |
| 14.2.2.Visiopharm A/S (Denmark) |
| 14.2.3.Laboratory Corporation of America Holdings (LabCorp) (U.S.) |
| 14.2.4.University Health Network (Canada) |
| 14.2.5.Canada Health Infoway |
| 14.2.7.Telemedicine Clinic (TMC) (Spain) |
| 14.2.8.microDimensions (Germany) |
| 14.2.9.AMD Global Telemedicine, Inc. (U.S.) |
| 14.2.10.Polycom, Inc. (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.